Literature DB >> 30154154

TIP: A Web Server for Resolving Tumor Immunophenotype Profiling.

Liwen Xu1, Chunyu Deng1, Bo Pang1, Xinxin Zhang1, Wei Liu1, Gaoming Liao1, Huating Yuan1, Peng Cheng1, Feng Li1, Zhilin Long1, Min Yan1, Tingting Zhao2, Yun Xiao3, Xia Li3.   

Abstract

: Systematically tracking the tumor immunophenotype is required to understand the mechanisms of cancer immunity and improve clinical benefit of cancer immunotherapy. However, progress in current research is hindered by the lack of comprehensive immune activity resources and easy-to-use tools for biologists, clinicians, and researchers to conveniently evaluate immune activity during the "cancer-immunity cycle." We developed a user-friendly one-stop shop web tool called TIP to comprehensively resolve tumor immunophenotype. TIP has the capability to rapidly analyze and intuitively visualize the activity of anticancer immunity and the extent of tumor-infiltrating immune cells across the seven-step cancer-immunity cycle. Also, we precalculated the pan-cancer immunophenotype for 11,373 samples from 33 The Cancer Genome Atlas human cancers that allow users to obtain and compare immunophenotype of pan-cancer samples. We expect TIP to be useful in a large number of emerging cancer immunity studies and development of effective immunotherapy biomarkers. TIP is freely available for use at http://biocc.hrbmu.edu.cn/TIP/. SIGNIFICANCE: TIP is a one-stop shop platform that can help biologists, clinicians, and researchers conveniently evaluate anticancer immune activity with their own gene expression data.See related commentary by Hirano, p. 6536. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30154154     DOI: 10.1158/0008-5472.CAN-18-0689

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  102 in total

1.  Interferon-Induced Transmembrane Protein 3 Shapes an Inflamed Tumor Microenvironment and Identifies Immuno-Hot Tumors.

Authors:  Yun Cai; Wenfei Ji; Chuan Sun; Rui Xu; Xuechun Chen; Yifan Deng; Jiadong Pan; Jiayue Yang; Hongjun Zhu; Jie Mei
Journal:  Front Immunol       Date:  2021-08-11       Impact factor: 7.561

2.  Machine learning algorithm-generated and multi-center validated melanoma prognostic signature with inspiration for treatment management.

Authors:  Zaoqu Liu; Hui Xu; Siyuan Weng; Chunguang Guo; Qin Dang; Yuyuan Zhang; Yuqing Ren; Long Liu; Libo Wang; Xiaoyong Ge; Zhe Xing; Jian Zhang; Peng Luo; Xinwei Han
Journal:  Cancer Immunol Immunother       Date:  2022-08-23       Impact factor: 6.630

3.  SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.

Authors:  Dong Pan; Xuhui Bao; Mengjie Hu; Meng Jiao; Fang Li; Chuan-Yuan Li
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

4.  IGFBP7 and the Tumor Immune Landscape: A Novel Target for Immunotherapy in Bladder Cancer.

Authors:  Xianyanling Yi; Xiaonan Zheng; Hang Xu; Jin Li; Tianyi Zhang; Peng Ge; Dazhou Liao; Hong Li; Xiaoyan Lyu; Jianzhong Ai
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma.

Authors:  Yang Zhou; Gai Li; Hu Li; Fuchong Lai; Pingguo Duan; Ming Cheng
Journal:  J Immunol Res       Date:  2022-07-04       Impact factor: 4.493

6.  A Gene Mutation Signature Predicting Immunotherapy Benefits in Patients With NSCLC.

Authors:  Dong Pan; Angela Y Hu; Scott J Antonia; Chuan-Yuan Li
Journal:  J Thorac Oncol       Date:  2020-12-08       Impact factor: 15.609

7.  Ferroptosis-related gene signature predicts prognosis and immunotherapy in glioma.

Authors:  Rong-Jun Wan; Wang Peng; Qin-Xuan Xia; Hong-Hao Zhou; Xiao-Yuan Mao
Journal:  CNS Neurosci Ther       Date:  2021-05-10       Impact factor: 5.243

8.  A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.

Authors:  Feng Jiang; Yan Mao; Binbin Lu; Guoping Zhou; Jimei Wang
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

9.  A Hypoxia Gene-Based Signature to Predict the Survival and Affect the Tumor Immune Microenvironment of Osteosarcoma in Children.

Authors:  Feng Jiang; Xiao-Lin Miao; Xiao-Tian Zhang; Feng Yan; Yan Mao; Chu-Yan Wu; Guo-Ping Zhou
Journal:  J Immunol Res       Date:  2021-07-15       Impact factor: 4.818

10.  Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma.

Authors:  Xiaomao Yin; Zaoyu Wang; Jianfeng Wang; Yunze Xu; Wen Kong; Jin Zhang
Journal:  Oncoimmunology       Date:  2021-06-30       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.